Participants 136 200 6
treatment of recurrent or refractory non small-cell lung cancer.
Participants 932 1054 5
All patients had histologically confirmed nonsquamous NSCLC that had progressed during or after one platinum-based regimen
Participants 1064 1126 7
One hundred twenty patients were randomly assigned and treated
